CompletedNot Applicable

Apexification Treatment With MTA(Mineral Trioxide Aggregate) and Ca(OH)2

90 participantsStarted 2015-01

Plain-language summary

Ninety immature teeth with necrotic pulps and periapical lesions on patients (aged 16-40y) were treated with AT using MTA (45 teeth) or CH (45 teeth) between 2015 and 2018. The patients were contacted for follow-up examination at 12 to 48 months after treatment. The treatment outcome based on clinical and radiographic criteria was assessed by calibrated examiners and dichotomized as "healed+healing" or "not healed". The age, gender, stage of root development, preoperative signs and symptoms of apical periodontitis and size of periapical lesion were recorded.

Who can participate

Age range16 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients without a systemic disease and compromised immune status * patients had immature teeth with periapical lesions with or without previous endodontic treatment. Exclusion Criteria: * patients with advanced periodontitis (more than 5 mm periodontal attachment and bone loss), * teeth with contraindications for endodontic treatment (root fracture, unrestorable tooth, replacement resorption or previous surgical endodontic treatment).

What they're measuring

The rate of the healing of the periapical lesion

Timeframe: 12 to 48 months

Trial details

NCT IDNCT03855501

SponsorEge University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-01

View on ClinicalTrials.gov More Immature Teeth trials